RELB anticorps (C-Term)
Aperçu rapide pour RELB anticorps (C-Term) (ABIN629859)
Antigène
Voir toutes RELB AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- RELB antibody was raised against the C terminal of RELB
-
Purification
- Purified
-
Immunogène
- RELB antibody was raised using the C terminal of RELB corresponding to a region with amino acids GPEPLTLDSYQAPGPGDGGTASLVGSNMFPNHYREAAFGGGLLSPGPEAT
-
-
-
-
Indications d'application
-
WB: 1.25 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
RELB Blocking Peptide, (ABIN938855), is also available for use as a blocking control in assays to test for specificity of this RELB antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of RELB antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- RELB (V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB))
-
Autre désignation
- RELB
-
Sujet
- RELB neither associates with DNA nor with RELA/p65 or REL. It stimulates promoter activity in the presence of NFKB2/p49.
-
Poids moléculaire
- 62 kDa (MW of target protein)
-
Pathways
- Signalisation NF-kappaB, Signalisation RTK
Antigène
-